###begin article-title 0
Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis
###end article-title 0
###begin p 1
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
2Professor Kudo died on April 27, 2008. We greatly miss him as a scientist and a friend. We offer sincere thanks to all the friends, colleagues and former collaborators of Professor Kudo who showed him kindness during his lifetime.
###end p 1
###begin p 2
###xml 142 143 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 160 161 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 211 212 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 594 602 594 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 607 614 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 707 708 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1662 1663 1653 1654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
###xml 1233 1237 <span type="species:ncbi:10090">mice</span>
###xml 1529 1533 <span type="species:ncbi:10090">mice</span>
###xml 1552 1556 <span type="species:ncbi:10090">mice</span>
mPGES-1 (microsomal prostaglandin E synthase-1) is a stimulus-inducible enzyme that functions downstream of COX (cyclo-oxygenase)-2 in the PGE2 (prostaglandin E2)-biosynthesis pathway. Although COX-2-derived PGE2 is known to play a role in the development of various tumours, the involvement of mPGES-1 in carcinogenesis has not yet been fully understood. In the present study, we used LLC (Lewis lung carcinoma) cells with mPGES-1 knockdown or overexpression, as well as mPGES-1-deficient mice to examine the roles of cancer cell- and host-associated mPGES-1 in the processes of tumorigenesis in vitro and in vivo. We found that siRNA (small interfering RNA) silencing of mPGES-1 in LLC cells decreased PGE2 synthesis markedly, accompanied by reduced cell proliferation, attenuated Matrigeltrade mark invasiveness and increased extracellular matrix adhesion. Conversely, mPGES-1-overexpressing LLC cells showed increased proliferating and invasive capacities. When implanted subcutaneously into wild-type mice, mPGES-1-silenced cells formed smaller xenograft tumours than did control cells. Furthermore, LLC tumours grafted subcutaneously into mPGES-1-knockout mice grew more slowly than did those grafted into littermate wild-type mice, with concomitant decreases in the density of microvascular networks, the expression of pro-angiogenic vascular endothelial growth factor, and the activity of matrix metalloproteinase-2. Lung metastasis of intravenously injected LLC cells was also significantly less obvious in mPGES-1-null mice than in wild-type mice. Thus our present approaches provide unequivocal evidence for critical roles of the mPGES-1-dependent PGE2 biosynthetic pathway in both cancer cells and host microenvironments in tumour growth and metastasis.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 310 311 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 466 467 466 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 586 587 586 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 758 759 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 796 797 796 797 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1178 1179 1178 1179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1376 1377 1376 1377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1482 1483 1482 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1484 1485 1484 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
Numerous studies on rodent cancer models and human cancers have shown that NSAIDs (non-steroidal anti-inflammatory drugs) have antineoplastic properties [1]. A well-known effect of the NSAIDs is their ability to inhibit the enzyme COX (cyclo-oxygenase) and thereby to suppress PG (prostaglandin) synthesis. PGE2, the most common PG, is involved in tumour progression by inducing angiogenesis, invasion and metastasis in several solid tumours [2]. Biosynthesis of PGE2 from arachidonic acid, which is spatiotemporally supplied from membrane phospholipids by the action of phospholipase A2, is catalysed sequentially by COX and PGES (PGE synthase) [3]. COX catalyses the insertion of molecular oxygen into arachidonic acid to form the unstable intermediate PGG2, which is rapidly converted into PGH2 by the peroxidase activity of the same enzyme. Of the two COX isoforms, COX-1 is expressed constitutively in most tissues and is generally responsible for the production of PGs that control normal physiological functions, whereas COX-2 is inducible in response to mitogens, cytokines and cellular transformation. High levels of constitutive expression of COX-2 and its product PGE2 have been detected in various cancer cells and tissues. Moreover, pharmacological, cell biological and gene targeting studies investigating COX-2 and EPs (PGE receptors) have demonstrated that PGE2 produced through the COX-2-dependent pathway contributes to the progression of several types of cancer [4,5].
###end p 4
###begin p 5
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 560 561 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1116 1117 1116 1117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1293 1295 1293 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1296 1298 1296 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1340 1341 1340 1341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1588 1589 1588 1589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1853 1854 1853 1854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1855 1857 1855 1857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1858 1860 1858 1860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 2029 2031 2029 2031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 2032 2034 2032 2034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1006 1011 <span type="species:ncbi:9606">human</span>
###xml 1124 1139 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 1476 1480 <span type="species:ncbi:10090">mice</span>
PGES catalyses the conversion of PGH2, produced by COX-1 or COX-2, into PGE2. Thus far, three PGES enzymes, mPGES (microsomal PGES)-1, mPGES-2 and cPGES (cytosolic PGES), have been identified [6-9]. Among these PGES isozymes, mPGES-1 is induced by pro-inflammatory stimuli and down-regulated by anti-inflammatory glucocorticoids, as in the case of COX-2, and is functionally coupled with COX-2 in marked preference to COX-1 [7,10,11]. Induction of mPGES-1 expression and its function have been observed in various diseases and systems in which COX-2-driven PGE2 has been implicated, such as rheumatoid arthritis, febrile response, reproduction, bone metabolism, cardiovascular function, stroke and Alzheimer's disease [12,13]. Furthermore, it has previously been reported that mPGES-1 is constitutively expressed in several cancers, most of which also express COX-2 constitutively [14,15]. We have reported that the forcible transfection of mPGES-1 in combination with COX-2, but not with COX-1, into HEK (human embryonic kidney)-293 cells led to cellular transformation with a concomitant and robust increase in PGE2 [14]. Transgenic mice overexpressing both COX-2 and mPGES-1 developed metaplasia, hyperplasia and tumorous growth in the glandular stomach with heavy macrophage infiltration [16,17]. It has also been suggested that the PGE2 produced through the COX-2-dependent pathway may regulate cancer-host communications that influence tumour progression. Studies using mice null for COX-2 or EPs have revealed that stromal cells around cancer cells express COX-2 and synthesize PGE2, which, in tumour niches, may act on stromal cells in an autocrine fashion to induce the production of pro-angiogenic factors and consequent angiogenesis, as well as on cancer cells in a paracrine fashion to promote their growth, survival, adhesion and motility [5,18-20]. Although several studies, including our own, have found, by immunohistochemistry, that mPGES-1 is expressed in both stromal cells and cancer cells in tumour tissues [14,21], the contribution of mPGES-1 expressed in either cell population to tumour progression has not yet been fully elucidated.
###end p 5
###begin p 6
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 408 409 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 868 876 868 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 881 888 881 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
Although the inhibition of COX-2-mediated PGE2 formation represents a promising chemopreventive strategy for reducing the risk of cancer, the cardiovascular side effects associated with COX-2 inhibitors, which most likely result from the blunting of anti-thrombotic prostacyclin (PGI2), have previously been found to limit their use [22,23]. From this viewpoint, selective blockage of the biosynthesis of PGE2 without affecting other prostanoids appears to be feasible for cancer chemoprevention with the potential for improved tolerability over NSAIDs. To better evaluate the efficacy of mPGES-1 inhibition in relieving symptoms of cancer, the present study used lung carcinoma cells with mPGES-1 KD (knockdown) or overexpression, as well as mice null for mPGES-1. Our results provide evidence that mPGES-1 in both cancer cells and hosts contributes to tumorigenesis in vitro and in vivo.
###end p 6
###begin title 7
EXPERIMENTAL
###end title 7
###begin title 8
Cells
###end title 8
###begin p 9
###xml 233 234 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:9913">calf</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
LLC (Lewis lung carcinoma) cells, which were originally isolated from C57BL/6 mice, were cultured in DMEM (Dulbecco's modified Eagle's medium) containing 10% (v/v) FCS (fetal calf serum) under a humidified atmosphere containing 5% CO2. To establish mPGES-1-KD and -overexpressing LLC cells, we transfected these cells with a pRNA-U6.1/Hygro siRNA (small interfering RNA) expression vector (GenScript) harboring an mPGES-1-directed siRNA target sequence [5'-GGCCTTTGCCAACCCCGAG-3' (residues 126-144 in the open reading frame)] and a pcDNA3.1 expression vector (Invitrogen) containing mouse mPGES-1 cDNA respectively, using Lipofectaminetrade mark 2000 (Invitrogen). After the transfection of these plasmids, LLC cells were cultured in medium containing 1 mg/ml G418 (Invitrogen) to establish stable clones. As a control, LLC cells transfected with an empty vector (pRNA-U6.1/Hygro or pcDNA3.1) were used (referred to as mock cells hereafter).
###end p 9
###begin title 10
Animals
###end title 10
###begin p 11
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
C57BL/6 and BALB/c mice were obtained from the Saitama Animal Center. mPGES-1-KO (knockout) mice were established as described previously [12,13], and backcrossed at least three generations with C57BL/6 mice or ten generations with BALB/c mice. Female mPGES-1-KO mice and littermate WT (wildtype) mice (7-weeks-old) were used in each experiment. The mice were housed in microisolator cages in a pathogen-free barrier facility, and all procedures involving animals were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of Showa University, in accordance with the Standards Relating to the Care and Management of Experimental Animals in Japan.
###end p 11
###begin title 12
Cell growth assay
###end title 12
###begin p 13
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 308 309 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells were seeded at 6x104 cells/well in six-well plates or 1.5x105 cells/flask in T-25 culture flasks in culture medium in the presence or absence of 10 nM NS-398 (Cayman Chemicals), a COX-2 selective inhibitor, or 1 mM dmPGE2 (16,16-dimethyl PGE2) (Cayman Chemicals), a metabolically stable analogue of PGE2. After culture for 72 h, the cells were collected by trypsinization and counted in a Bright-line haemocytometer in the presence of Trypan Blue.
###end p 13
###begin title 14
Western blot analysis
###end title 14
###begin p 15
###xml 507 509 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 547 549 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1187 1188 1178 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1189 1191 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1192 1194 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 712 717 <span type="species:ncbi:10090">mouse</span>
###xml 841 852 <span type="species:ncbi:3704">horseradish</span>
###xml 880 884 <span type="species:ncbi:9925">goat</span>
###xml 919 925 <span type="species:ncbi:9986">rabbit</span>
###xml 975 980 <span type="species:ncbi:10090">mouse</span>
Aliquots of samples (20 mug of protein equivalents) were subjected to SDS/PAGE using 10% (w/v) gels under reducing conditions. The separated proteins were electroblotted on to nitrocellulose membranes (Schleicher & Schuell) with a semi-dry blotter (Bio-Rad). After blocking with 3% (w/v) dried non-fat skimmed milk in TBS (Tris-buffered saline) (pH 7.4) containing 0.05% Tween 20 (TBS-Tween), the membranes were probed with the respective antibodies for 2 h {1:2000 dilution for antibodies against mPGES-1 [14], mPGES-2 (Cayman Chemicals), cPGES [11], COX-1 and -2 (Santa Cruz Biotechnology), EP1, 2, 3 and 4 (Cayman Chemicals), and VEGF (vascular endothelial growth factor; Sigma); and 1:2500 dilution for anti-mouse alpha-tubulin antibody (Zymed Laboratories) in TBS-Tween}. After washing with TBS-Tween, the membranes were incubated with horseradish peroxidase-conjugated anti-goat (for COX-1, COX-2 and VEGF), anti-rabbit (for mPGES-1, mPGES-2, cPGES and EP1-4) and anti-mouse (for alpha-tubulin) IgG antibodies (1:5000 dilution in TBS-Tween) for 1 h, and visualized with the ECL (enhanced chemiluminescence) Western blot system (PerkinElmer Life Sciences), as described previously [7,13,14]. Amounts of individual proteins relative to that of alpha-tubulin were estimated from their signal intensities on the Western blots using Lane and Spot Analyzer (ATTO).
###end p 15
###begin title 16
Determination of PG levels
###end title 16
###begin p 17
###xml 289 291 288 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 393 395 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 417 418 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 423 424 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
For the measurement of PGs in tissues, mouse tissues were washed twice with Hank's balanced salt solution containing 10 muM indomethacin (Sigma) before homogenization. The supernatants obtained from the tissue homogenates were adjusted to pH 3.0 with 1 M HCl and passed through a Sep-Pak C18 cartridge (Waters), and the retained PGs were eluted with 8 ml of methanol, as described previously [13]. A trace amount of [3H]PGE2 (Cayman Chemicals) was added to the samples before passage through the cartridges to calibrate the recovery of the PGs. The sample solvents were evaporated, and then the PGs were dissolved in an aliquot of buffer and assayed with commercial enzyme immunoassay kits for individual PGs (Cayman Chemicals). Likewise, aliquots of the supernatants of cultured cells were subjected to the enzyme immunoassay for PGs.
###end p 17
###begin title 18
Adhesion assay
###end title 18
###begin p 19
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Cells were plated at 2x105 cells in 35-mm dishes, which were pre-treated with collagen, fibronectin or laminin (BD Biosciences). After incubation for 60 min at 37 degreesC, the cells were fixed with Carnoy solution and then stained with Giemsa solution for 60 min. Adherent cells were counted in three fields at x40 magnification using a microscope and J image software.
###end p 19
###begin title 20
Invasion assay
###end title 20
###begin p 21
###xml 183 184 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 857 858 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 672 678 <span type="species:ncbi:3635">cotton</span>
Cell invasiveness was evaluated using a BD BioCoattrade mark Matrigeltrade mark Invasion Chamber (BD Biosciences) according to the manufacturer's instructions. In brief, cells (1.2x106 cells in 0.5 ml) suspended in DMEM containing 3% (v/v) FCS and 1% (v/v) sodium pyruvate (Invitrogen) were seeded on the top of the gel in each chamber. DMEM containing 10% (v/v) FCS (0.75 ml) was added as a source of chemoattractants into the bottom wells of the plate. After 16 h of incubation, cells that had invaded on to the lower surface of the chamber were fixed with methanol for 5 min, and stained with Crystal Violet. Non-invasive cells on the upper surface were removed with a cotton bud, and the membrane was cut. The number of invading cells was quantified by counting them under a light microscope. Statistical significance was determined using the Student's t test.
###end p 21
###begin title 22
Tumour implantation model
###end title 22
###begin p 23
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 337 338 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 340 341 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 342 343 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W</italic>
###xml 343 344 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 357 358 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 367 368 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 380 381 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W</italic>
###xml 389 391 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
LLC cells (1x106) in 100 mul of PBS were injected subcutaneously into 8-week-old female mice. Tumour growth was assessed by the measurement of two bisecting diameters in each tumour using calipers. The size of the tumour was determined by direct measurement of the tumour dimensions. The volume was calculated according to the equation: V=(LxW2)x0.5, where V=volume, L=length and W=width [35]. On day 14 after tumour implantation, the mice were anaesthetized and killed by dislocation of the cervical spine, and the tumour tissues were dissected, weighed and then fixed in 10% (v/v) formalin for histochemical analyses. The intratumoral blood vessels in the most intensive neovascularization areas were quantified by staining of the sections with haematoxylin and eosin followed by silver. For each tumour, five random images were captured at x400 magnification. Only areas of viable tumour tissue were imaged; necrotic regions were excluded. The individual microvessels were counted. The structure of individual microvessels was clearly differentiated from tumour cells on silver staining. The final vascular density score for the tumour represents an average of all scored fields.
###end p 23
###begin title 24
Lung metastasis model
###end title 24
###begin p 25
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
LLC cells (1x106) in 100 mul of PBS were intravenously injected into the lateral tail veins of 8-week-old female mice. Then, 14 days later, the mice were anaesthetized and killed, and the lungs were removed and weighed. Finally, the lungs were placed in Bouin's solution for 24 h and then photographed.
###end p 25
###begin title 26
Determination of haemoglobin levels in tumour tissues
###end title 26
###begin p 27
###xml 318 319 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 318 319 317 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
###xml 406 407 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 406 407 404 405 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>g</italic></bold>
The dissected tumour tissues were washed, cut into small pieces with scissors, and homogenized with a Polytron homogenizer in a SET buffer [250 mM sucrose, 0.5 mM EDTA and 20 mM Tris/HCl (pH 7.4)] containing 10 muM indomethacin, 1 mM PMSF and 0.5% Triton X-100. The tissue homogenates obtained were centrifuged at 600 g for 5 min, and an aliquot (200 mul) of the supernatant was centrifuged again at 14000 g for 30 min at 4 degreesC. Concentrations of haemoglobin in the supernatant were then determined spectrophotometrically by measuring the absorbance at 540 nm using a haemoglobin assay kit (Wako).
###end p 27
###begin title 28
RT (reverse transcriptase)-PCR
###end title 28
###begin p 29
###xml 140 166 <span type="species:ncbi:11866">avian myeloblastosis virus</span>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
Total RNA was isolated from cells and tissues using TRIzol(R) (Invitrogen). Synthesis of cDNA was performed with 2 mug of the total RNA and avian myeloblastosis virus RT according to the manufacturer's instructions supplied with the RNA PCR kit version 2.1 (Takara Biomedicals). Subsequent amplifications of the partial cDNA fragments were performed using 0.5 mul of the reverse-transcribed mixture as a template with a set of specific oligonucleotide primers (Sigma) as follows: (i) mouse VEGF, sense 5'-GATGAAGCCCTGGAGTGC-3' and antisense 5'-TCCCAGAAACAACCCTAA-3'; and (ii) mouse GAPDH (glyceraldehyde-3-phosphate dehydrogenase), sense 5'-TCGTGGATCTGACGTGCCGCCTG-3' and antisense 5'-CACCACCCTBTTGCTGTAGCCGTAT-3'. The PCR mixtures were subjected to 30 cycles of amplification by denaturation (30 s at 94 degreesC), annealing (30 s at 57 degreesC) and elongation (30 s at 72 degreesC). The PCR products were analysed by 1% (w/v) agarose gel electrophoresis with ethidium bromide.
###end p 29
###begin title 30
Real-time RT-PCR
###end title 30
###begin p 31
###xml 78 104 <span type="species:ncbi:11866">avian myeloblastosis virus</span>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 465 470 <span type="species:ncbi:10090">mouse</span>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 655 660 <span type="species:ncbi:10090">mouse</span>
###xml 774 779 <span type="species:ncbi:10090">mouse</span>
###xml 870 875 <span type="species:ncbi:10090">mouse</span>
###xml 978 983 <span type="species:ncbi:10090">mouse</span>
###xml 1167 1172 <span type="species:ncbi:10090">mouse</span>
Single-stranded cDNA was generated using 1 mug of total RNA as a template and avian myeloblastosis virus RT, using a high capacity reverse transcriptase kit (Applied Biosystems). Real-time PCR was carried out using the SYBR Green PCR Master Mix (Applied Biosystems) and StepOne (Applied Biosystems) according to the manufacturer's instructions. The PCR primer sets used were: (i) mouse EP2, sense 5'-GCTGTGCTCGCCTGCAA-3' and antisense 5'-CGACGGTGCATGCGAAT-3'; (ii) mouse EP4, sense 5'-CATCATCTGTGCCATGAGCAT-3' and antisense 5'-GCTGTAGAAGTAGGCGTGGTTGA-3'; (iii) mouse VEGF, sense 5'-TACCTCCACCATGCCAAGTG-3' and antisense 5'-TGGGACTTCTGCTCTCCTTCTG-3'; (iv) mouse MMP (matrix metalloproteinase)-2, sense 5'-GGACCCCGGTTTCCCTAA-3' and antisense 5'-CAGGTTATCAGGGATGGCATTC-3'; (v) mouse MMP-9, sense 5'-AGTGGGACCATCATAACATCACAT-3' and antisense 5'-TCTCGCGGCAAGTCTTCAG-3'; (vi) mouse alpha5 integrin, sense 5'-ATGGCTCAGACATCCACTCC-3' and antisense 5'-GGTCATCTAGCCCATCTCCA-3'; and (vii) mouse beta1 integrin, sense 5'-GGTGTCGTGTTTGTGAATGC-3' and antisense 5'-TGACGCTAGACATGGACCAG-3'. The expression levels of EP2, EP4, MMP-2, MMP-9 and integrins were normalized with those of mouse GAPDH with a primer set of 5'-ATGTGTCCGTCGTGGATCTGA-3' and 5'-ATGCCTGCTTCACCACCTTCT-3'. Results represent an average of several independent experiments.
###end p 31
###begin title 32
Gelatin zymography
###end title 32
###begin p 33
###xml 356 357 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 372 373 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Lysates of cells and tissues (27 mug of protein equivalents) were subjected to SDS/PAGE (10% gels), with 1 mg/ml gelatin substrate being incorporated into the gels. Following electrophoresis, the gels were soaked in 2.5% Triton X-100 to remove SDS, rinsed with 10 mM Tris/HCl (pH 8.0), and transferred to a bath containing 50 mM Tris/HCl(pH 8.0), 5 mM CaCl2 and 1 muM ZnCl2 at 37 degreesC for 18 h. The gels were then stained with 0.1% Coomassie Blue in 45% methanol and 10% acetic acid.
###end p 33
###begin title 34
RESULTS
###end title 34
###begin title 35
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Reduced tumorigenic potential of mPGES-1-silenced LLC cells in vitro
###end title 35
###begin p 36
###xml 186 187 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 267 275 267 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 497 505 497 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 610 611 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 851 859 851 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 979 987 979 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1114 1115 1114 1115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1215 1223 1215 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1254 1260 1254 1256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#945;</sub>
###xml 1303 1304 1299 1300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1313 1319 1309 1311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1377 1385 1369 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
We established mPGES-1-KD LLC cells by means of an siRNA- silencing strategy, as described in the Experimental section. The expression levels of mPGES-1 and other enzymes involved in PGE2 synthesis in mPGES-1-KD and mock cells were examined by Western blot analysis (Figure 1A). The expression level of mPGES-1 was reduced by ~80% in mPGES-1-KD cells relative to mock cells, whereas those of COX-1 and -2 and other PGE synthases (cPGES and mPGES-2) in both cell lines were approximately the same (Figure 1A, left-hand panel). Furthermore, we found that, among the four EP receptor subtypes that can bind to PGE2 [24], LLC cells expressed detectable levels of EP2, EP3 and EP4 proteins, among which the level of EP2 protein was reduced in mPGES-1-KD cells relative to mock cells, whereas the levels of EP3 and EP4 were unaffected by mPGES-1 silencing (Figure 1A, left-hand panel). The reduction in EP2, but not EP4, expression in the KD cells was verified by quantitative RT-PCR (Figure 1A, right-hand panel) and quantifying individual immunoblots by a densitometer (Supplementary Figure S1 at ). The amounts of PGE2 released into the medium during culture were decreased in mPGES-1-KD cells relative to mock cells (Figure 1B), whereas those of 6-keto PGF1alpha (a non-enzymatic hydrolytic product of PGI2) and PGF2alpha were comparable between mPGES-1-KD cells and mock cells (Figure 1C).
###end p 36
###begin title 37
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
PGE2 production and cell proliferation in mPGES-1-silenced LLC cells in vitro
###end title 37
###begin p 38
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 581 582 580 581 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 583 584 582 583 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 682 683 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 685 686 684 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 699 705 698 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#945;</sub>
###xml 713 719 708 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 721 722 712 713 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 752 753 743 744 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 801 802 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1084 1085 1075 1076 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1102 1103 1093 1094 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1197 1198 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1270 1271 1260 1261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A) Expression of PGE2 biosynthetic enzymes and PGE receptors in mPGES-1-KD and control (mock) cells was assessed by immunoblotting (left-hand panel). Equal amounts of cell lysates (20 mug of protein equivalents) were separated by SDS/PAGE and analysed by Western blotting at the same time with the corresponding antibodies to allow for a direct comparison. Representative results of at least three experiments are shown. Expression levels of EP2 and EP4 mRNAs in KD and mock cells were evaluated by quantitative RT-PCR, with GAPDH mRNA used for normalization (right-hand panel). (B-D) Effects of mPGES-1 silencing and 10 nM NS-398, a COX-2 selective inhibitor, on production of PGE2 (B), 6-keto PGF1alpha and PGF2alpha (C), and on cell proliferation (D). mPGES-1-KD and mock cells were seeded at 6x104 cells/well in six-well culture dishes in the presence or absence of 10 nM NS-398. After culture for 3 days, the cells were collected and counted in a Bright-line haemocytometer in the presence of Trypan Blue, and the supernatants were taken for enzyme immunoassay of several PGs. (E) Effect of dmPGE2 on cell proliferation. mPGES-1-KD and mock cells were seeded in T-25 culture flasks at 1.5x105 cells/flask in culture medium in the presence or absence of 1 muM dmPGE2. After culture for 3 days, the cells were collected and counted. Values are the means+/-S.E.M. Similar results were obtained in three independent cell lines of mPGES-1-KD and control cells.
###end p 38
###begin p 39
###xml 69 77 69 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 309 318 309 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 353 359 353 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#945;</sub>
###xml 367 373 363 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 426 434 418 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 659 660 650 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 689 690 680 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 692 700 683 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 738 739 729 730 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Concurrently, mPGES-1-KD cells grew more slowly than did mock cells (Figure 1D). NS-398, a COX-2-selective inhibitor, suppressed PGE2 generation and cell proliferation in mock cells by ~60% and ~25% respectively, whereas no further decreases in PGE2 production and cell growth were found in mPGES-1-KD cells (Figures 1B and 1D). Production of 6-keto PGF1alpha and PGF2alpha was equally sensitive to NS-398 in both cell lines (Figure 1C). Furthermore, cell growth of mPGES-1-KD cells was partially (even if not completely, probably because EP2 expression was reduced in the KD cells; see above) restored by addition of an optimal concentration (1 muM) of dmPGE2, a synthetic analogue of PGE2 (Figure 1E). These results suggest that the PGE2 produced through the COX-2/mPGES-1 pathway is partially required for the proliferation of LLC cells.
###end p 39
###begin p 40
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 374 382 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 546 547 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 751 753 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 949 957 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1310 1318 1292 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1385 1393 1367 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1436 1437 1418 1419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In the process of tumour metastasis, cancer cells from the primary tumour must invade the ECM (extracellular matrix). There are many reports demonstrating that malignant tumour cells often possess high invasive activity [25]. Thus we next assessed the effect of mPGES-1 silencing on the invasive activity of LLC cells using Matrigeltrade mark invasion chambers. As shown in Figure 2(A), the number of mPGES-1-KD cells migrating across the Matrigeltrade mark-coated filter was markedly fewer than that of mock cells. Since it is known that the PGE2 signalling activates the invasive potential of cancer cells by increasing the expressions of VEGF, a pro-angiogenic factor, and MMPs, which hydrolyse type IV collagen localized in the basement membrane [25], we next examined the effects of mPGES-1 silencing on the expression of VEGF and the activities of MMP-2 and -9 by Western blot analysis, gelatin zymography and quantitative RT-PCR. As shown in Figure 2(B), the activities of MMP-2 and -9 in the conditioned medium from mPGES-1-KD cells were lower than those in the medium from mock cells. Consistently, expression levels of both MMP-2 and -9 mRNAs were significantly reduced in the KD cells relative to control cells. In contrast, the levels of VEGF protein and mRNA were unaffected by mPGES-1 silencing (Figure 2B). These results suggest that the silencing of mPGES-1 diminishes in vitro migration of LLC cells by reducing the PGE2-induced expression of MMP-2 and -9.
###end p 40
###begin title 41
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
siRNA silencing of mPGES-1 in LLC cells reduces their malignant potential in vitro
###end title 41
###begin p 42
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 651 652 622 623 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1228 1229 1192 1193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1458 1459 1414 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1484 1485 1440 1441 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1572 1573 1528 1529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1716 1717 1671 1672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2035 2036 1982 1983 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2447 2448 2378 2379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
(A) mPGES-1-KD and mock cells [1.2x106 cells in DMEM containing 3% (v/v) FCS] were seeded on to the upper wells of BD BioCoattrade mark Matrigeltrade mark Invasion Chambers. DMEM containing 10% (v/v) FCS was added as a source of chemoattractants into the bottom wells of the plates. After 16 h of incubation, cells that had invaded on to the lower surface of the chambers were fixed, stained with Crystal Violet and counted (left-hand panel). Values are the means+/-S.E.M. of five independent experiments. Representative photographs of mPGES-1-KD and mock cells that invaded across the Matrigeltrade mark-coated inserts are shown (right-hand panel). (B) The expression of VEGF protein in mPGES-1-KD and mock cells was assessed by immunoblotting (upper panel). The cell lysates (20 mug of protein equivalents) were separated by SDS/PAGE and then subjected to Western blot analysis using anti-VEGF and anti-alpha-tubulin antibodies. The activities of MMP-2 and -9 in mPGES-1-KD and mock cells were assessed by gelatin zymography (lower panel). Lysates of cells (27 mug of protein equivalents) were subjected to SDS/PAGE containing 1 mg/ml gelatin. Following electrophoresis, the gels were incubated in a bath containing 1 muM ZnCl2 at 37 degreesC for 18 h. The gels were then stained with 0.1% Coomassie Blue. The expression levels of mRNAs for VEGF, MMP-2 and MMP-9 were evaluated by quantitative RT-PCR, with GAPDH mRNA used for normalization (means+/-S.D.; n=3) (right-hand panel). (C) Adhesion of mPGES-1-KD and mock cells to ECM proteins. mPGES-1-KD or mock cells (2x105 cells) were seeded on to 35-mm dishes coated with collagen, fibronectin or laminin in culture medium in the presence or absence of 1 muM dmPGE2. After allowing cells to attach for 60 min at 37 degreesC, non-adherent cells were removed by washing. Adherent cells were fixed and stained with Giemsa solution and counted in three fields at x40 magnification using a microscope and J image software. Values are the means+/- S.E.M. of five independent experiments. (D) Expression of alpha5 and beta1 integrins in mPGES-1-KD and mock cells. Total RNA was isolated from mPGES-1-KD and mock cells and subjected to quantitative RT-PCR using specific primers of alpha5 (left-hand panel) and beta1 (right-hand panel) integrins and those of GAPDH as a reference. The results of quantitative RT-PCR were normalized with their expression in mock cells being regarded as 1 (means+/-S.D., n=3). Similar results were obtained in two independent cell lines of mPGES-1-KD and control cells.
###end p 42
###begin p 43
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 180 188 180 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 507 515 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 605 606 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 706 714 706 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 936 944 929 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1008 1009 1001 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The ability of cancer cells to adhere to the ECM influences their motility and invasion in tumour tissues in vivo, and metastatic tumour cells show decreased ECM-adherent activity in vitro [25,26]. Therefore we next studied the attachment of mPGES-1-KD or mock cells to culture dishes pre-coated with distinct ECM components. The results showed that the numbers of mPGES-1-KD cells adhering to collagen and fibronectin, but not to laminin, were significantly increased as compared with those of mock cells (Figure 2C). Moreover, the increased adhesion of mPGES-1-KD cells to collagen was reversed by dmPGE2 to the level of mock cells, and adhesion of the cells to fibronection also showed a similar trend (Figure 2C). Consistent with the increased binding of mPGES-1-KD cells to collagen and fibronectin, the expressions of their receptor components, alpha5 and beta1 integrins, were elevated in the KD cells relative to control cells (Figure 2D). Thus we conclude that mPGES-1 supplies a majority of the PGE2 that enhances the malignant potential (in terms of ECM invasion and adherence) of cancer cells.
###end p 43
###begin title 44
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Increased tumorigenic potential of mPGES-1-overexpressing LLC cells in vitro
###end title 44
###begin p 45
###xml 316 324 316 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 331 332 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 453 461 453 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 477 485 477 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 756 764 747 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 884 892 875 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 954 955 945 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
We next established LLC cells that stably overexpressed mPGES-1 and examined whether these cells (as opposed to mPGES-1-KD cells) would show increased proliferation and invasion. mPGES-1-transfected LLC cells expressed more mPGES-1 protein than did mock cells, whereas the expression of COX-2 protein was unaltered (Figure 3A). PGE2 release into the medium during culture was increased by ~2-fold in mPGES-1-overexpressing cells relative to mock cells (Figure 3B). As shown in Figure 3(C), the growth rate of mPGES-1-overexpressing cells was significantly faster than that of mock cells. Moreover, the Matrigeltrade mark invasion chamber assay revealed that the invasive activity of mPGES-1-overexpressing cells was notably higher than that of mock cells (Figure 3D). Additionally, treatment of both mock and mPGES-1-overexpressing LLC cells with NS-398 reduced the invasion by ~40% (Figure 3D). These results confirm that the increased production of PGE2 through the COX-2/mPGES-1 pathway in cancer cells facilitates their proliferation and invasion.
###end p 45
###begin title 46
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Increased PGE2 generation, proliferation and invasion of mPGES-1-overexpressing LLC cells
###end title 46
###begin p 47
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 181 182 181 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 187 188 187 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 244 245 244 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 557 558 555 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 605 606 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
(A) Expression of COX-2 and mPGES-1 in mPGES-1-overexpressing and mock cells was assessed by Western blot analysis. Representative results of at least three experiments are shown. (B and C) Effects of mPGES-1 overexpression on PGE2 generation (B) and cell growth (C). mPGES-1-overexpressing and mock cells were seeded at 6x104 cells/well in six-well culture dishes. After culture for 2 days, the cells were collected and counted, and the supernatants were taken for a PGE2 enzyme immunoassay. Values are the means+/-S.E.M. of five independent experiments. (D) mPGES-1-overexpressing and mock cells (1.2x106 cells in the presence or absence of 10 nM NS-398) that had invaded through BD BioCoattrade mark Matrigeltrade mark Invasion Chamber inserts over 16 h were counted. Values are the means+/-S.E.M. of five independent experiments. Similar results were obtained in two independent cell lines of mPGES-1-overexpressing and mock cells.
###end p 47
###begin title 48
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Silencing of mPGES-1 in cancer cells reduces tumorigenesis in vivo
###end title 48
###begin p 49
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 414 423 414 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4</xref>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 464 465 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 470 476 470 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 491 498 487 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#945;)</sub>
###xml 599 600 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 697 705 689 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 854 862 846 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 950 958 942 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 960 968 952 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1028 1035 1020 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1081 1082 1073 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
To assess the contribution of mPGES-1 in cancer cells to tumour development in vivo, we grafted mPGES-1-KD and mock LLC cells subcutaneously into BALB/c mice, and the development of the solid tumour around the injection sites was evaluated on day 14 after implantation. Remarkably, both the volume and mass of xenografts derived from mPGES-1-KD cells were significantly smaller than those derived from mock cells (Figures 4A and 4B). The levels of prostanoids (PGE2, PGF2alpha and 6-keto-PGF1alpha) in the homogenates of xenografts did not differ significantly between the genotypes, even though PGE2 tended to decrease in the xenografts from mPGES-1-KD cells compared with those from mock cells (Figure 4C). The expression of VEGF, as assessed by RT-PCR and quantitative RT-PCR, was reduced in mPGES-1-KD xenografts as compared with control xenografts (Figure 4D). Considering that VEGF expression was unaltered by silencing of mPGES-1 in LLC cells in vitro (Figure 2B), the reduction of VEGF expression in mPGES-KD xenografts in vivo may reflect the action of mPGES-1-derived PGE2 from cancer cells on proximal stromal cells in tumour microenvironments.
###end p 49
###begin title 50
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
siRNA silencing of mPGES-1 in cancer cells reduces tumorigenesis in vivo
###end title 50
###begin p 51
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 3 4 3 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W</italic>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 203 204 203 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 284 285 284 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 311 312 311 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 361 362 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 368 369 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 385 386 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 391 397 389 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 412 418 406 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#945;</sub>
###xml 511 512 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 518 519 506 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 762 763 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
(A-C) mPGES-1-KD or mock cells (106 cells) were injected into the subcutaneous tissue of female BALB/c mice. On day 14 after implantation, tumour volume was scored according to the formula V=(LxW2)x0.5 (A, left-hand panel). The tumour tissues were photographed at x100 magnification (B), dissected and weighed (A, right-hand panel). Values are means+/- S.E.M. (n=9). (C) Amounts of PGE2, PGF2alpha and 6-keto PGF1alpha in homogenates of the tumour tissues were quantified by enzyme immunoassay (means+/-S.E.M., n=9). (D) Expression of VEGF in tumour xenografts of mPGES-1-KD and mock cells was assessed by RT-PCR followed by electrophoresis (left-hand panel) and quantitative RT-PCR (right-hand panel), with the expression of GAPDH as a reference (means+/-S.D., n=4).
###end p 51
###begin title 52
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Reduced tumour growth and angiogenesis in mPGES-1-KO mice
###end title 52
###begin p 53
###xml 114 115 114 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 984 992 984 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1101 1109 1101 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1147 1148 1147 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1273 1279 1273 1275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1328 1336 1324 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
###xml 955 959 <span type="species:ncbi:10090">mice</span>
###xml 1056 1060 <span type="species:ncbi:10090">mice</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
###xml 1231 1235 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
The observations described above indicate that cancer cell-associated COX-2 and mPGES-1 co-operatively produce PGE2, which accelerate multiple steps of malignant progression, including cell proliferation, invasion and ECM adhesion. In terms of the pathological circumstances, it has been reported that COX-2 and mPGES-1 are expressed not only in tumour cells, but also in the stromal cells (mainly in infiltrating macrophages) surrounding them [14,21]. To investigate the contribution of host-associated mPGES-1 to tumour growth, we next grafted parental LLC cells subcutaneously into either mPGES-1-KO or WT mice, and evaluated the development of solid tumour around the injection sites. Although the absence of mPGES-1 in the host mice influenced neither the engraftment rate nor the growth of tumours during the first 5 days after implantation, tumours grafted into the mPGES-1-KO mice were significantly smaller in size than those grafted into the WT mice after day 6 and beyond (Figure 5A). On day 14 after implantation, the tumour mass in mPGES-1-KO mice was reduced to half of that in WT mice (Figure 5B, left-hand panel). The levels of PGE2 in homogenates of the dissected tumour tissues were nearly 50% less in mPGES-1-KO mice than in WT mice, whereas those of PGF2alpha were unaffected by the host mPGES-1 deficiency (Figure 5B, right-hand panel).
###end p 53
###begin title 54
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Growth of LLC cells subcutaneously implanted into mPGES-1-KO and WT mice
###end title 54
###begin p 55
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 99 100 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 194 195 194 195 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 306 307 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 315 321 315 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 462 463 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 469 470 463 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 685 686 679 680 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 869 870 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 899 900 891 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1304 1305 1290 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
A total of 105 cells were injected into the subcutaneous tissue of female mPGES-1-KO and WT mice. (A) Tumour volumes were scored on the indicated days as described in the Experimental section. (B) On day 14 after implantation, the tumour tissues were dissected and weighed (left-hand panel). Amounts of PGE2 and PGF2alpha in homogenates of the tumour tissues were quantified by enzyme immunoassay (right-hand panel). Results are presented as the means+/-S.E.M. (n=9). (C) Tumour tissues were cut out, fixed in formalin, and stained with silver, haematoxylin and eosin for histochemical analysis. Microvessels and necrotic regions are shown by arrowheads and an asterisk respectively. (D) Vascular density (left-hand panel) and haemoglobin content (right-hand panel) were determined as described in the Experimental section. Results are presented as the means+/-S.E.M. (n=9). HPF, high-power field. (E) Expression levels of VEGF protein (upper panel) and mRNA (lower panel) in the tumour tissues were determined by Western blot and RT-PCR analysis respectively. Representative results of six independent experiments are shown. On Western blot analysis, the expression level of VEGF protein was quantified by a densitometer, with the expression level of alpha-tubulin used for normalization (means+/-S.D., n=6) (right-hand panel).
###end p 55
###begin p 56
###xml 156 164 156 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 305 313 305 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 559 567 559 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 736 744 736 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 926 934 926 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1126 1134 1122 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1207 1208 1203 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1372 1380 1368 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1382 1390 1378 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1524 1525 1520 1521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1582 1589 1578 1585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
###xml 1474 1478 <span type="species:ncbi:10090">mice</span>
Histological examination of the xenografts revealed that the vascularization of tumour tissues was markedly reduced by the lack of host mPGES-1 expression (Figure 5C, indicated by arrowheads). The vascular density was approx. 60% lower in tumours grafted in mPGES-1-KO mice than those grafted in WT mice (Figure 5D, left-hand panel). The haemoglobin contents in the tumour tissues, which appeared to be well correlated with tumour neovascularization upon histological examination [30], were also reduced in mPGES-1-KO mice in comparison with that in WT mice (Figure 5D, right-hand panel). The reduction of tumour angiogenesis in mPGES-1-KO mice caused a large area of central necrosis in the xenografts of mPGES-1-KO, but not WT, mice (Figure 5C, indicated by an asterisk). We further found that the expression levels of the VEGF protein and mRNA in tumour tissues were also markedly lower in mPGES-1-KO mice than in WT mice (Figure 5E, left-hand panel). The decrease in VEGF protein in the xenografts of mPGES-1-KO mice was confirmed by quantification of the relative abundance of VEGF to alpha-tubulin using a densitometer (Figure 5E, right-hand panel). These results suggest that host mPGES-1-derived PGE2 plays a pivotal role in tumour-associated VEGF production and accompanying angiogenesis. Again, considering that VEGF expression was unaltered in mPGES-1-KD cells in vitro (Figure 2B), the reduced expression of this angiogenic factor in tumour tissue in mPGES-1-KO mice may reflect the impact of mPGES-1-derived PGE2 on tumour microenvironments rather than on tumour cells in vivo.
###end p 56
###begin p 57
###xml 312 320 312 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 337 345 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 559 567 559 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 748 757 748 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 763 764 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 925 933 925 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1060 1068 1060 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1137 1138 1137 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
We further examined the role of host-associated mPGES-1 in tumour metastasis by intravenous injection of parental LLC cells into mPGES-1-KO and WT mice. After 14 days, macroscopic metastases, as assessed by Bouin's staining, were found in the lungs of both genotypes, but the number and size of metastatic foci (Figure 6A) and the mass (Figure 6B, left-hand panel) of the lungs were significantly reduced in mPGES-1-KO mice compared with WT mice. Levels of PGE2 were reduced by nearly 50% in homogenates of the lungs from mPGES-1-KO mice relative to WT mice (Figure 6B, right-hand panel). Moreover, as assessed by RT-PCR and quantitative RT-PCR, VEGF expression in the metastasized lungs was significantly lower in mPGES-1-KO mice than in WT mice (Figures 6C and 6E). Gelatin zymography revealed that the activity of MMP-2 in the metastasized lung tissues was mitigated in mPGES-1-KO mice in comparison with that in WT mice (Figure 6D), and the levels of both MMP-2 and -9 mRNAs were significantly lower in the lung of mPGES-1-KD mice than in that of WT mice (Figure 6E). Collectively, these results indicate that host mPGES-1-driven PGE2 plays a role in promoting tumour development and metastasis, which was associated with increased VEGF expression and MMP-2 and -9 activation.
###end p 57
###begin title 58
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Reduced lung metastasis in mPGES-1-KO mice
###end title 58
###begin p 59
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 210 211 210 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 270 271 270 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 288 289 288 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 375 376 375 376 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 398 399 398 399 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 462 463 462 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 575 576 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 584 585 582 583 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 660 661 658 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 663 664 661 662 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 669 670 667 668 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 674 675 672 673 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 827 828 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
A total of 105 cells were injected into the lateral tail veins of female mPGES-1-KO and WT mice on the BALB/c background. On day 14 after implantation, the mice were killed, and the removed lungs were weighed (B, left-hand panel) and then stained with Bouin's solution (A). Amounts of PGE2 in homogenates of the metastasized lung tissues were measured by enzyme immunoassay (B, right-hand panel). (C) Expression of VEGF and GAPDH mRNAs were assessed by RT-PCR. (D) Activities of MMP-2 and -9 were evaluated by gelatin zymography. Results are presented as the means+/-S.E.M. (n=4) in (B) and representative results of four independent experiments are shown in (A, C and D). (E) The expression levels of mRNAs for VEGF, MMP-2 and MMP-9 were evaluated by quantitative RT-PCR, with GAPDH mRNA used for normalization (means+/-S.D., n=4).
###end p 59
###begin title 60
DISCUSSION
###end title 60
###begin p 61
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 501 502 501 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 511 512 511 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1125 1133 1125 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1167 1174 1167 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1569 1577 1569 1577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1582 1589 1582 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
Although the concept that the PGE2 produced through the COX-2-dependent pathway participates in the pathogenesis of several types of cancer has been well established in the past decade based on a series of genetic studies employing mice ablated for the biosynthetic enzymes (COX-2) and receptors (EPs) or pharmacological studies employing inhibitors or agonists/antagonists fairly specific for them, the contribution of a step between COX-2 and EPs, namely PGES enzymes that convert COX-2-produced PGH2 into PGE2, to cancer development has remained incompletely understood. In this context, we have previously shown that co-transfection of mPGES-1 in combination with COX-2 into HEK-293 cells leads to a malignant phenotype [14]. In our continuing efforts to gain further insights into the role of mPGES-1 in tumorigenesis, we used two approaches in the present study. First, we performed siRNA-mediated silencing and overexpression of mPGES-1, which enabled us to address the complementary effects of endogenous compared with overexpressed mPGES-1 in cancer cells on tumorigenic potentials (growth, invasion and ECM binding in vitro and tumour xenograft propagation in vivo). Secondly, implantation of carcinoma cells into mPGES-1-KO mice and WT mice allowed us to evaluate the contribution of mPGES-1 expressed in tissue microenvironments to the development and metastasis of tumours in proximal and distant tissues. Our results clearly indicate that mPGES-1 expressed in both cancer cells and hosts is capable of promoting proliferation and invasion of cancer cells in vitro and in vivo.
###end p 61
###begin title 62
Role of mPGES-1 in cancer cells
###end title 62
###begin p 63
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 88 97 88 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 162 175 162 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figures 3A&#8211;3C</xref>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 337 338 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 515 524 515 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figures 2</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 721 722 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 908 909 908 909 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1012 1014 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1118 1126 1118 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1385 1387 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1388 1390 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1405 1413 1405 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1543 1544 1543 1544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1736 1744 1729 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1923 1925 1916 1918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1951 1952 1944 1945 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 208 213 <span type="species:ncbi:10090">mouse</span>
We found that PGE2 generation and cell proliferation were reduced by mPGES-1 knockdown (Figures 1A, 1B and 1D) and conversely enhanced by mPGES-1 overexpression (Figures 3A-3C) in LLC cells (a PGE2-dependent mouse lung carcinoma cell line; [27]), indicating the role of mPGES-1, acting downstream of COX-2, in providing the mitogenic PGE2. In accordance with the impact on cell proliferation, the gene silencing of mPGES-1 decreased, whereas overexpression of mPGES-1 increased, the invasive activity of LLC cells (Figures 2A and 3D). The process by which tumour cells break out from their site of origin and metastasize to distant sites requires an ability to invade through the ECM and underlying mesenchymal cells. PGE2 stimulates the invasion of cancer cells through up-regulating MMP-2 and MMP-9 (type IV collagenases), as shown by the observations that MMP-2 is increased in COX-2-overexpressing or PGE2-treated tumour cells [25,26,28,29], and that MMP-9 is induced by COX-2/EP4 signalling in macrophages [30]. We found that the expression of MMP-2 and -9 in mPGES-1-KD cells were lower than that in mock cells (Figure 2B), suggesting the contribution of these matrix-degrading proteases to the mPGES-1dependent invasiveness of LLC cells. In addition to adhesion to and degradation of the ECM, detachment from the ECM is also an important step in the metastasis of tumour cells [25,26]. As shown in Figure 2(C), both collagen- and fibronectin-adherent activities were significantly increased in mPGES-1-KD cells, and treatment with dmPGE2 reversed these activities consistently. Accordingly, the expression of integrin alpha5beta1 (a major adhesion molecule of fibronectin) in mPGES-1-KD cells was higher than that in mock cells (Figure 2D), an observation that is reminiscent of our previous report that co-overexpression of COX-2 and mPGES-1 in HEK-293 cells results in a marked reduction in a subset of integrins [14]. Thus mPGES-1-driven PGE2 may regulate the ECM-adherent activity of cancer cells by altering the expression of integrins.
###end p 63
###begin p 64
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 156 164 156 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 243 244 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 281 289 281 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 574 575 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 606 608 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 609 611 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 747 749 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 750 752 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 824 825 817 818 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 943 945 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 946 948 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 997 998 990 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1126 1128 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1326 1334 1319 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1376 1377 1369 1370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1603 1604 1596 1597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 417 422 <span type="species:ncbi:9606">human</span>
Importantly, in vivo tumour growth after subcutaneous engraftment of mPGES-1-KD cells was less obvious than that after engraftment of replicate mock cells (Figure 4), implying that mPGES-1 contributes to the supply of the major pool of the PGE2 mediating tumour proliferation both in vitro and in vivo. Gene disruption of EP2 resulted in a reduced number and size of intestinal polyps in Apc-mutant mice, a model for human familial adenomatous polyposis [31], and the Apc mutation is accompanied by aberrant activation of beta-catenin signalling, which is accelerated by PGE2 through the EP2-Gsalpha axis [32,33]. In another model, disruption of the gene for EP1, EP2 or EP4 suppressed the development of colorectal cancer induced by carcinogens [34-36]. Transactivation of EGF (epidermal growth factor) receptors by the PGE2/EP1, 2, or 4 signalling via protein kinase A and c-Src led to increased cell growth and invasion of carcinoma cells [37-39]. In a positive-feedback loop, COX-2-derived PGE2 acts on EP2, leading to the elevation of intracellular cAMP, which in turn up-regulates the expressions of both COX-2 and EP2 [40]. Although the identification of EPs participating in the propagation of LLC xenografts is beyond the scope of the present study, the co-ordinated reduction of mPGES-1 and EP2 in mPGES-1-KD cells (Figure 1A) suggests that COX-2/mPGES-1-derived PGE2 may stimulate EP2 signalling in an autocrine/paracrine fashion to facilitate LLC cell proliferation and, accordingly, defects in mPGES-1 may lead to down-regulation of EP2 and eventually reduce the cellular sensitivity to PGE2.
###end p 64
###begin p 65
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 257 259 253 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</italic>
###xml 252 259 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;<italic>14</italic></sup>
###xml 325 327 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 399 402 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 402 405 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">min</italic>
###xml 402 405 398 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>min</italic></sup>
###xml 467 468 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
While this paper was in preparation, two groups reported opposite effects of mPGES-1 deficiency in intestinal tumorigenesis. Nakanishi et al. [41] showed that the genetic deletion of mPGES-1 ameliorates the development of intestinal tumours in both ApcDelta14-dependent and carcinogen-induced models, whereas Elander et al. [42] demonstrated that intestinal polyposis is exacerbated in mPGES-1-null Apcmin mutant mice, probably because of the metabolic shift from PGE2 towards other pro-tumorigenic lipid mediators. Although the reason for the discrepancy between these two studies is unclear, our present results appear to be in line with the former study and thus support the feasibility of targeting mPGES-1 for cancer chemoprevention. Critically, although the experimental design of the previous studies did not allow a precise distinction between the contribution of cancer cell- and host-associated mPGES-1 to tumour development, our present approach clearly underscores the importance of mPGES-1 pools both in cancer cells (as discussed above) and in microenvironments (see below).
###end p 65
###begin title 66
Role of mPGES-1 in host microenvironments
###end title 66
###begin p 67
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 149 150 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 475 484 475 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figures 5</xref>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 587 588 587 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 696 703 696 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1229 1231 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 1212 1227 <span type="species:ncbi:10090">transgenic mice</span>
As is COX-2, mPGES-1 is expressed in stromal cells as well as in cancerous cells in several types of tumour [14,15]. Given that stromal COX-2 and PGE2 of the host can influence the development of grafted tumours [20,43], we used mPGES-1-KO mice to evaluate the potential roles of the host stromal mPGES-1 in tumour growth, and found that tumour growth at a proximal site and metastasis into a distant tissue were significantly reduced in mPGES-1-KO mice relative to WT mice (Figures 5 and 6). This result provides an additional line of genetic evidence that the COX-2/mPGES-1-derived PGE2 from host stromal cells, in addition to that from cancer cells (see above), is important for tumorigenesis in vivo. The induction of mPGES-1 in tumour stromal tissues may be ascribed to the migration and expansion of host inflammatory cells and neovascular endothelial cells, since previous immunohistochemical analyses have demonstrated a preferential localization of mPGES-1 in macrophage-like cells infiltrating into the stromal tissues in proximity to cancer cells [14], and since massive macrophage infiltration and microvessel formation have been observed in the stroma of gastric hyperplasia in COX-2/mPGES-1-double transgenic mice [16,17].
###end p 67
###begin p 68
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 667 668 667 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 917 920 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 1245 1253 1245 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1440 1442 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 1583 1592 1583 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 1598 1599 1598 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 1640 1641 1640 1641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1204 1208 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1304 1308 <span type="species:ncbi:10090">mice</span>
###xml 1350 1354 <span type="species:ncbi:10090">mice</span>
###xml 1561 1565 <span type="species:ncbi:10090">mice</span>
###xml 1577 1581 <span type="species:ncbi:10090">mice</span>
As shown in Figure 5, vascular density and VEGF expression in tumour xenografts were decreased in mPGES-1-KO mice. It has been reported that angiogenesis induced by either endogenous COX-2 or exogenous PGE2 was accompanied by increased VEGF expression and was abolished by a VEGF-directed antisense oligonucleotide [19]. Moreover, the growth, VEGF expression and angiogenesis of LLC-implanted tumours were markedly suppressed in EP3-KO mice [43], a phenotype that is reminiscent of mPGES-1-KO (the present study) and COX-2-KO mice [20]. These studies indicate that, in the tumour milieu, both cancer cells and adjacent stromal cells synthesize (via COX-2/mPGES-1) PGE2, which in turn acts on the particular population of EP3-expressing stromal cells to induce the production of VEGF and consequent angiogenesis [43]. Consistently, Nakanishi et al. [41] have reported very recently that genetic deletion of mPGES-1 in Apc-mutant mice caused marked and persistent suppression of intestinal cancer growth in association with a disorganized vascular pattern. In addition to tumour growth and associated angiogenesis, lung metastasis of LLC cells across the blood circulation was also decreased in mPGES-1-KO mice as compared with replicate WT mice (Figure 6). The metastatic phenotype observed in mPGES-1-KO mice was similar to that observed in MMP-2-KO mice, in which focal xenograft propagation and lung metastasis of LLC cells were reduced [44]. In agreement, MMP-2, as well as MMP-9, expression in the metastasized lung tissues was markedly lower in mPGES-1-KO mice than in WT mice (Figures 6D and 6E). Thus, in the metastatic foci, the PGE2 derived from the host mPGES-1 may lead to the increase in the activities of MMP-2 and -9, which, in co-operation with VEGF, may promote the invasion of cancerous cells into the adjacent and distant tissues, thereby allowing subsequent expansion and metastasis of the tumour.
###end p 68
###begin p 69
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 729 730 729 730 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 900 905 <span type="species:ncbi:9606">human</span>
In conclusion, the results of the present study suggest that both cancer cell-associated and host-derived mPGES-1 is critical for tumour growth and metastasis. The mPGES-1-driven PGE2 signalling on stromal cells may be functionally linked to the induction of potent pro-angiogenic and matrix-degrading factors, which in turn would facilitate tumour development. Previous studies have shown that, unlike the specific inhibition of COX-2, which predisposes to cardiovascular risk, gene ablation of mPGES-1 in mice shows minimal unfavourable effects on the circulation system [12]. Therefore an mPGES-1 inhibitor would exhibit a chemopreventive action on various tumours by attenuating both cancer cell- and stromal cell-derived PGE2, thereby serving as a novel therapeutic tool for cancer. Future clinical studies will address the important question of the efficacy and safety of mPGES-1 inhibition in human diseases.
###end p 69
###begin title 70
Online data
###end title 70
###begin title 71
Supplementary data
###end title 71
###begin title 72
AUTHOR CONTRIBUTION
###end title 72
###begin p 73
Daisuke Kamei designed and performed the experiments, analysed the data and contributed to writing the manuscript; Yuka Sasaki also performed the experiments; Yoshihito Nakatani, Masataka Majima, Yukio Ishikawa and Toshiharu Ishii helped in manuscript and scientific discussions; Satoshi Uematsu and Shizuo Akira provided the resources for the work; Ichiro Kudo designed the experiments; and Makoto Murakami and Shuntaro Hara designed the experiments and also wrote the manuscript.
###end p 73
###begin title 74
ACKNOWLEDGEMENTS
###end title 74
###begin p 75
We would like to thank Dr S. Oh-Ish (Kitasato Institute, Saitama, Japan) for providing us with helpful suggestions.
###end p 75
###begin title 76
FUNDING
###end title 76
###begin p 77
###xml 37 121 37 121 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs1">Showa University Special Grant-in-Aid for Innovative Collaborative Research Projects</funding-source>
###xml 123 342 123 342 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs2">Grants-in-Aid for Scientific Research and &#8220;High-Tech Research Center&#8221; Project for Private Universities [matching fund subsidy (2004&#8211;2007)] from the Ministry of Education, Science, Culture, Sports and Technology of Japan</funding-source>
###xml 344 461 344 461 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs3">Grants-in-Aid for Comprehensive Research on Aging and Health from the Ministry of Health, Labour and Welfare of Japan</funding-source>
###xml 467 562 467 562 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs4">Japan Society for the Promotion of Science for Young Scientists (a Research Fellowship to D.K.)</funding-source>
###xml 568 629 568 629 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs5">PRESTO from the Japan Science and Technology Agency (to M.M.)</funding-source>
This work was supported in part by a Showa University Special Grant-in-Aid for Innovative Collaborative Research Projects; Grants-in-Aid for Scientific Research and "High-Tech Research Center" Project for Private Universities [matching fund subsidy (2004-2007)] from the Ministry of Education, Science, Culture, Sports and Technology of Japan; Grants-in-Aid for Comprehensive Research on Aging and Health from the Ministry of Health, Labour and Welfare of Japan; the Japan Society for the Promotion of Science for Young Scientists (a Research Fellowship to D.K.); and PRESTO from the Japan Science and Technology Agency (to M.M.)
###end p 77
###begin article-title 78
Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer
###end article-title 78
###begin article-title 79
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Prostaglandin E2 increases growth and motility of colorectal carcinoma cells
###end article-title 79
###begin article-title 80
###xml 74 75 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway
###end article-title 80
###begin article-title 81
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
###end article-title 81
###begin article-title 82
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
###end article-title 82
###begin article-title 83
###xml 18 23 <span type="species:ncbi:9606">human</span>
Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
###end article-title 83
###begin article-title 84
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 Synthase that acts in concert with cyclooxygenase-2
###end article-title 84
###begin article-title 85
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis
###end article-title 85
###begin article-title 86
Identification and characterization of a novel type of membraneassociated prostaglandin E synthase
###end article-title 86
###begin article-title 87
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Cloning, expression, and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis
###end article-title 87
###begin article-title 88
Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells
###end article-title 88
###begin article-title 89
Membrane prostaglandin E synthase-1: a novel therapeutic target
###end article-title 89
###begin article-title 90
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1
###end article-title 90
###begin article-title 91
Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis
###end article-title 91
###begin article-title 92
Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis
###end article-title 92
###begin article-title 93
###xml 78 93 <span type="species:ncbi:10090">transgenic mice</span>
Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice
###end article-title 93
###begin article-title 94
###xml 198 213 <span type="species:ncbi:10090">transgenic mice</span>
Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice
###end article-title 94
###begin article-title 95
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
###end article-title 95
###begin article-title 96
###xml 138 141 <span type="species:ncbi:10116">rat</span>
Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants
###end article-title 96
###begin article-title 97
Host cyclooxygenase-2 modulates carcinoma growth
###end article-title 97
###begin article-title 98
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2
###end article-title 98
###begin article-title 99
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
###end article-title 99
###begin article-title 100
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
###end article-title 100
###begin article-title 101
Prostanoid receptors: structures, properties, and functions
###end article-title 101
###begin article-title 102
Tumor metastasis: mechanistic insights and clinical challenges
###end article-title 102
###begin article-title 103
Tumour-cell invasion and migration: diversity and escape mechanisms
###end article-title 103
###begin article-title 104
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages
###end article-title 104
###begin article-title 105
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion
###end article-title 105
###begin article-title 106
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2
###end article-title 106
###begin article-title 107
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages
###end article-title 107
###begin article-title 108
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 80 89 80 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Delta 716</italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc (Delta 716) knockout mice
###end article-title 108
###begin article-title 109
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis
###end article-title 109
###begin article-title 110
Cyclooxygenase-2 and colorectal cancer chemoprevention: the beta-catenin connection
###end article-title 110
###begin article-title 111
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis
###end article-title 111
###begin article-title 112
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development
###end article-title 112
###begin article-title 113
Prostaglandin E receptor subtype EP1 deficiency inhibits colon cancer development
###end article-title 113
###begin article-title 114
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
###end article-title 114
###begin article-title 115
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 117 118 113 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway
###end article-title 115
###begin article-title 116
Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways
###end article-title 116
###begin article-title 117
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin
###end article-title 117
###begin article-title 118
Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis
###end article-title 118
###begin article-title 119
###xml 71 76 71 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC<sup>Min/+</sup></italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APCMin/+ mice
###end article-title 119
###begin article-title 120
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth
###end article-title 120
###begin article-title 121
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
###end article-title 121

